Tag: ticagrelor monotherapy
“No red flags” for ticagrelor monotherapy according to stent type
George Dangas (New York, USA) discusses the results of the TWILIGHT-Stent trial, presented at the...
GLOBAL LEADERS: no sex-difference in mortality or MI rates two years after PCI, but bleeding risk higher in women than men
A prespecified subgroup analysis of the GLOBAL LEADERS trial has found no between-sex difference...
TCT 2019: Aspirin withdrawal after three months of dual antiplatelet therapy reduces bleeding without an increase in ischaemic events among high-risk patients following PCI
Data from the TWILIGHT study demonstrate that, compared to ticagrelor plus aspirin, ticagrelor m...
